Koyfin Home > Directory > Health Care > Amphastar Pharma > Issuance of Common Stock

Amphastar Pharma Issuance of Common Stock Chart (AMPH)

Amphastar Pharma annual/quarterly Issuance of Common Stock from 2014 to 2018.
  • Amphastar Pharma Issuance of Common Stock for the quarter ending September 09, 2018 was $26m a 83.59% increase of 22m year over year
  • Amphastar Pharma Issuance of Common Stock for the last 12 months ending September 09, 2018 was $33m a 58.28% increase of 19m year over year
  • Amphastar Pharma Annual Issuance of Common Stock for 2017 was $14m a -56.29% decrease of -8m from 2016
  • Amphastar Pharma Annual Issuance of Common Stock for 2016 was $22m a 33.46% increase of 7m from 2015
  • Amphastar Pharma Annual Issuance of Common Stock for 2015 was $14m a -166.98% decrease of -24m from 2014
Other Cash Flow Metrics:
  • Amphastar Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $16m a 38.12% increase of 6m year over year
  • Amphastar Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 389.71% increase of 8m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Issuance of Common Stock Data

09/2018$26m
12/2017$7m
06/2017$7m
12/2016$4m
09/2016$14m
06/2016$3m
12/2015$3m
09/2015$1m
06/2015$10m
03/2015$1m

Annual AMPH Issuance of Common Stock Data

2017$14m
2016$22m
2015$14m
2014$38m
2013$0m